{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:41:44Z","timestamp":1791582104845,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,17]],"date-time":"2021-10-17T00:00:00Z","timestamp":1634428800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1111\/ajt.16867","type":"journal-article","created":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T14:29:58Z","timestamp":1634653798000},"page":"813-822","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["SARS-CoV-2-specific humoral and cell-mediated immune responses after immunization with inactivated COVID-19 vaccine in kidney transplant recipients (CVIM 1 study)"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0930-8936","authenticated-orcid":false,"given":"Jackrapong","family":"Bruminhent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chavachol","family":"Setthaudom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pongsathon","family":"Chaumdee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarinya","family":"Boongird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasisopin","family":"Kiertiburanakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumthorn","family":"Malathum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3876-9432","authenticated-orcid":false,"given":"Arkom","family":"Nongnuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angsana","family":"Phuphuakrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sopon","family":"Jirasiritham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chitimaporn","family":"Janphram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sansanee","family":"Thotsiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supparat","family":"Upama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3835-175X","authenticated-orcid":false,"given":"Montira","family":"Assanatham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1111\/ajt.16867_bib1","doi-asserted-by":"crossref","first-page":"e0239250","DOI":"10.1371\/journal.pone.0239250","article-title":"Clinical characteristics and risk factors for coronavirus disease 2019 (COVID-19) among patients under investigation in Thailand","volume":"15","author":"Bruminhent","year":"2020","journal-title":"PLoS One."},{"issue":"2","key":"10.1111\/ajt.16867_bib2","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/cid\/ciaa863","article-title":"COVID-19 in immunocompromised hosts: what we know so far","volume":"72","author":"Fung","year":"2021","journal-title":"Clin Infect Dis."},{"issue":"6","key":"10.1111\/ajt.16867_bib3","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1097\/TP.0000000000003670","article-title":"Outcomes of COVID-19 in solid organ transplant recipients: a propensity-matched analysis of a large research network","volume":"105","author":"Hadi","year":"2021","journal-title":"Transplant."},{"issue":"4","key":"10.1111\/ajt.16867_bib4","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/iid3.337","article-title":"A family cluster of diagnosed coronavirus disease 2019 (COVID-19) kidney transplant recipient in Thailand","volume":"8","author":"Sakulkonkij","year":"2020","journal-title":"Imm Inflamm Dis."},{"issue":"1","key":"10.1111\/ajt.16867_bib5","doi-asserted-by":"crossref","first-page":"e13388","DOI":"10.1111\/tid.13388","article-title":"A case of successful treatment of severe COVID-19 pneumonia with favipiravir and tocilizumab in post-kidney transplant recipient","volume":"23","author":"Thammathiwat","year":"2021","journal-title":"Transpl Infect Dis."},{"issue":"5","key":"10.1111\/ajt.16867_bib6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med."},{"issue":"27","key":"10.1111\/ajt.16867_bib7","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med."},{"issue":"9","key":"10.1111\/ajt.16867_bib8","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.7326\/M21-1341","article-title":"Safety and immunogenicity of anti-SARS-CoV-2 messenger RNA vaccines in recipients of solid organ transplants","volume":"174","author":"Marion","year":"2021","journal-title":"Ann Intern Med."},{"issue":"21","key":"10.1111\/ajt.16867_bib9","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1001\/jama.2021.7489","article-title":"Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients","volume":"325","author":"Boyarsky","year":"2021","journal-title":"JAMA."},{"issue":"17","key":"10.1111\/ajt.16867_bib10","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1001\/jama.2021.4385","article-title":"Immunogenicity of a single dose of SARS-CoV-2 messenger RNA vaccine in solid organ transplant recipients","volume":"325","author":"Boyarsky","year":"2021","journal-title":"JAMA."},{"issue":"10","key":"10.1111\/ajt.16867_bib11","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa2107715","article-title":"Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile","volume":"385","author":"Jara","year":"2021","journal-title":"N Engl J Med."},{"issue":"2","key":"10.1111\/ajt.16867_bib12","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2215\/CJN.03791106","article-title":"Therapeutic monitoring of calcineurin inhibitors for the nephrologist","volume":"2","author":"Schiff","year":"2007","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1111\/ajt.16867_bib13","doi-asserted-by":"crossref","unstructured":"Azzi Y, Raees H, Wang T, Cleare L, Liriano-Ward L, Loarte-Campos P, et al. Risks factors associated with poor response to COVID-19 vaccination in kidney transplant recipients. Kidney Int. doi: 10.1016\/j.kint.2021.08.019","DOI":"10.1016\/j.kint.2021.08.019"},{"issue":"9","key":"10.1111\/ajt.16867_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2020.05.036","article-title":"Clinical evaluation of serological IgG antibody response on the Abbott Architect for established SARS-CoV-2 infection","volume":"26","author":"Chew","year":"2020","journal-title":"Clin Microbiol Infect."},{"key":"10.1111\/ajt.16867_bib15","unstructured":"Coronavirus diagnostics by Euroimmun. SARS-CoV-2 NeutraLISA. https:\/\/www.coronavirus-diagnostics.com\/documents\/Indications\/Infections\/Coronavirus\/EI_2606_D_UK_F.pdf. Published 2021. Updated on September 7, 2021. Accessed July 28, 2021."},{"issue":"5","key":"10.1111\/ajt.16867_bib16","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41590-021-00902-8","article-title":"Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection [published correction appears in Nat Immunol. 2021;22(7):928]","volume":"22","author":"Zuo","year":"2021","journal-title":"Nat Immunol."},{"key":"10.1111\/ajt.16867_bib17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s40506-021-00249-6","article-title":"COVID-19 in Solid Organ Transplant Recipients: a Review of the Current Literature","volume":"13","author":"Heldman","year":"2021","journal-title":"Curr Treat Options Infect Dis."},{"issue":"7","key":"10.1111\/ajt.16867_bib18","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1056\/NEJMc2108861","article-title":"Three doses of an mRNA Covid-19 vaccine in solid-organ transplant recipients","volume":"385","author":"Kamar","year":"2021","journal-title":"N Engl J Med."},{"issue":"9","key":"10.1111\/ajt.16867_bib19","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1097\/TP.0000000000003835","article-title":"Letter to editor: COVID-19 in kidney transplant recipients vaccinated with Oxford-AstraZeneca COVID-19 vaccine (Covishield): a single center experience from India","volume":"105","author":"Meshram","year":"2021","journal-title":"Transplantation."},{"issue":"2","key":"10.1111\/ajt.16867_bib20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1473-3099(20)30843-4","article-title":"Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18\u201359 years: a randomised, double-blind, placebo-controlled, phase 1\/2 clinical trial","volume":"21","author":"Zhang","year":"2021","journal-title":"Lancet Infect Dis."},{"key":"10.1111\/ajt.16867_bib21","doi-asserted-by":"crossref","unstructured":"Mok CKP, Cohen CA, Cheng SMS, et al. Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID-19 vaccines in Hong Kong: an observational cohort study. https:\/\/ssrn.com\/abstract=3884943. Published 2021. Accessed July 28, 2021.","DOI":"10.2139\/ssrn.3884943"},{"issue":"8","key":"10.1111\/ajt.16867_bib22","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1111\/ajt.16701","article-title":"Cellular and humoral response after mRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients","volume":"21","author":"Cucchiari","year":"2021","journal-title":"Am J Transplant."},{"issue":"2","key":"10.1111\/ajt.16867_bib23","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.transproceed.2013.11.063","article-title":"Comparison of the immunogenicity of a monovalent influenza A\/H1N1 2009 vaccine between healthy individuals, patients with chronic renal failure, and immunocompromised populations","volume":"46","author":"Watcharananan","year":"2014","journal-title":"Transplant Proc."},{"issue":"7","key":"10.1111\/ajt.16867_bib24","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJMoa1315727","article-title":"Efficacy of high-dose versus standard-dose influenza vaccine in older adults","volume":"371","author":"DiazGranados","year":"2014","journal-title":"N Engl J Med."},{"issue":"11","key":"10.1111\/ajt.16867_bib25","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1093\/cid\/cix1082","article-title":"A double-blind, randomized trial of high-dose vs standard-dose influenza vaccine in adult solid-organ transplant recipients","volume":"66","author":"Natori","year":"2018","journal-title":"Clin Infect Dis."},{"key":"10.1111\/ajt.16867_bib26","doi-asserted-by":"crossref","unstructured":"Odongo FCA, Braga PE, Palacios R, et al. An open-label randomized controlled parallel-group pilot study comparing the immunogenicity of a standard-, double- and booster-dose regimens of the 2014 seasonal trivalent inactivated influenza vaccine in kidney transplant recipients [published online ahead of print 2021]. Transplant. 2021. doi:10.1097\/TP.0000000000003702","DOI":"10.1097\/TP.0000000000003702"},{"issue":"7872","key":"10.1111\/ajt.16867_bib27","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41586-021-03739-1","article-title":"Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2","volume":"596","author":"Collier","year":"2021","journal-title":"Nature."},{"issue":"7","key":"10.1111\/ajt.16867_bib28","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat Med."}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.16867","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajt.16867","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522081345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522081345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.16867","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:36:46Z","timestamp":1761629806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522081345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1600613522081345"],"URL":"https:\/\/doi.org\/10.1111\/ajt.16867","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.08.02.21261095","asserted-by":"object"}]},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SARS-CoV-2-specific humoral and cell-mediated immune responses after immunization with inactivated COVID-19 vaccine in kidney transplant recipients (CVIM 1 study)","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.16867","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}